Digital Repository

Activation of the c-Jun N-terminal Kinase/Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search Repository


Advanced Search

Browse

My Account